SUBSCRIBE
SUBSCRIBE
Events

Introduction to RNA-Targeting Therapeutics

ABOUT THE EVENT

Date: Friday, January 23, 2026 8–9am PST
Event Location: Virtual

📅 January 23rd, 8:00 AM PSTThis opening session provides a practical foundation for understanding how mutation-specific RNA therapies are designed, engineered, and deployed in clinical settings. Topics include precision targeting, turning genes up or down, correcting splicing errors, minimizing off-target effects, and real-world clinical examples from diseases such as SMA, DMD, and ALS.

LEARN MORE
MORE EVENTS
Events
Register: Lean Derisking: Taking Your Proof of Concept to the Clinic
Taking an early proof of concept into preclinical and clinical development is a costly and complex process. But there are strategic ways to streamline the process and reduce risk and costs. In this webinar, you’ll hear directly from Nobel Laureate Sir Michael Houghton and experts from Applied Pharma, who bring decades of real-world success and deep scientific expertise.
Tuesday, February 24, 2026 12–1pm EST
 · 
Virtual
Events
Register: The Future is Collaborative: Transforming Clinical Trials
In this webinar, leading oncology experts Dr. Javier Cortés and Dr. Antonio Llombart-Cussac will explore how collaborative-initiated trials are transforming the clinical research landscape and creating new opportunities for scientific and clinical impact.
Monday, March 2, 2026 11am–12pm EST
 · 
Virtual
Events
Register: Operationalizing AI in Drug Development: Inside DIA’s Global AI Consortium
Artificial intelligence is rapidly reshaping the life sciences, from automating repetitive tasks to enabling advanced scientific and safety assessments across drugs, biologics, and devices. As adoption grows across regulators, pharmaceutical companies, technology developers, nonprofits, and collaborative consortia, the need for clear, risk-based frameworks for validation, governance and human oversight becomes increasingly critical.
Tuesday, March 17, 2026 1–2pm EDT
 · 
Virtual
More Events